ARCHIVES

In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely

This article is from The Cancer Letter archive.

Vol. 19 No. 42 | October 29, 1993

Download PDF Visit The Full Archive

Related Articles

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

In Brief: Livingston Completes Term On NCI Board, Appelbaum To Succeed Him as Chairman

November 12, 1999

Duke recruits Judd Moul as chief of urology.

July 9, 2004